-
1
المؤلفون: Zhuming Zhang (1846087), Peter J. Connolly (2456890), Heng Keang Lim (6057113), Vineet Pande (2538973), Lieven Meerpoel (1457320), Christopher Teleha (10009764), Jonathan R. Branch (10009767), Janine Ondrus (10009770), Ian Hickson (1981597), Tammy Bush (10009773), Leopoldo Luistro (10009776), Kathryn Packman (93334), James R. Bischoff (124533), Salam Ibrahim (10009779), Christopher Parrett (10009782), Yolanda Chong (3863953), Marco M. Gottardis (107229), Gilles Bignan (1889356)
مصطلحات موضوعية: Biochemistry, Medicine, Microbiology, Cell Biology, Genetics, Pharmacology, Cancer, Hematology, Infectious Diseases, Plant Biology, Computational Biology, Mathematical Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, Information Systems not elsewhere classified, F 877L Metabolite identification st., prostate cancer, CRPC, bioactivation pathway, AR mutations, second-generation AR pathway inhibitors, Wild-Type Castration-Resistant Pros., F 877L Mutant, point mutations, activation drives, pan-AR antagonist, next-generation AR antagonist, resistance mechanism, Clinical Stage Androgen Receptor An., castration-resistant prostate cancer, Persistent androgen receptor
-
2
المؤلفون: Zhuming Zhang (1846087), Peter J. Connolly (2456890), Heng Keang Lim (6057113), Vineet Pande (2538973), Lieven Meerpoel (1457320), Christopher Teleha (10009764), Jonathan R. Branch (10009767), Janine Ondrus (10009770), Ian Hickson (1981597), Tammy Bush (10009773), Leopoldo Luistro (10009776), Kathryn Packman (93334), James R. Bischoff (124533), Salam Ibrahim (10009779), Christopher Parrett (10009782), Yolanda Chong (3863953), Marco M. Gottardis (107229), Gilles Bignan (1889356)
مصطلحات موضوعية: Biochemistry, Medicine, Microbiology, Cell Biology, Genetics, Pharmacology, Cancer, Hematology, Infectious Diseases, Plant Biology, Computational Biology, Mathematical Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, Information Systems not elsewhere classified, F 877L Metabolite identification st., prostate cancer, CRPC, bioactivation pathway, AR mutations, second-generation AR pathway inhibitors, Wild-Type Castration-Resistant Pros., F 877L Mutant, point mutations, activation drives, pan-AR antagonist, next-generation AR antagonist, resistance mechanism, Clinical Stage Androgen Receptor An., castration-resistant prostate cancer, Persistent androgen receptor